Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
'Tis the Season… for Performance Reviews Performance reviews, often seen as dreadful, can become valuable opportunities for feedback and growth when integrated into a well-structured…
Read More →Aldevron, a Danaher company and global leader in the production of DNA, RNA, and proteins for genomic medicine, and Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodal biosafety testing provider, announced the renewal of their lentiviral plasmid licensing agreement designed to expand access to scalable plasmid solutions […]
In conversation with Heffron’s Matt McGrath on the people and projects enabling innovation to scale In life sciences, the spotlight often falls on discovery—on the science, the therapeutics, the breakthroughs. But behind every lab, cleanroom, and manufacturing suite is a different kind of expertise: the people responsible for building the environments where innovation can actually […]
When large pharmaceutical service businesses change hands, the headline is usually about the deal size. But the formation of Rose BioSolutions following GI Partners’ acquisition of Charles River Laboratories’ CDMO and Cell Solutions businesses signals something larger: infrastructure for advanced therapies is being repositioned as a long-term strategic asset rather than a volatile services add-on. […]
Innovation districts, when done right, have created incredible economic impact across the country, but many still struggle with the same challenge: creating actual ecosystems instead of collections of buildings. That’s the distinction Amy Adams wants people to understand about Nexus234. “We really are building a community,” Adams said during a recent episode of What’s the […]
From CMC strategy and analytics to CDMO partnerships and AI-enabled operations, life sciences ecosystem gathered at Propel Labs to discuss the growing pressure to execute with speed and precision. The biotech industry is entering a new phase where breakthrough science alone is no longer enough to attract capital, reach the clinic, or survive long enough […]
Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus platform from LTS-101 in CLN2 disease expected in 4Q 2026; multiple fast follow-ons utilize the same capsid for larger indications Proprietary engineered AAV capsids combined with optimal routes […]
The 8th Annual Women in Bio HERstory Gala 2026 brought together professionals across the life sciences field to celebrate leadership, community, and the women shaping the future of the industry. Women in Bio (WIB) is a global organization dedicated to advancing women in the life sciences through leadership skill development, mentorship, and community building. The […]
For scientists, giving back isn’t always simple. Volunteering requires a balance of time, access, and intention. I moved to Maryland from my home state of Wisconsin in October 2020, at the height of the pandemic. Like many others who relocated to the Capital Region for its density of scientific opportunity, I arrived knowing I was […]
Breaking into the U.S. healthcare market has traditionally been a slow, uncertain process for international companies, marked by regulatory complexity, fragmented systems, and long commercialization timelines. But at the WorldUpstart Winter Showcase in Philadelphia on April 27, a different pattern began to take shape. The companies in the room weren’t there to explore the U.S. […]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
